Switzerland· 68322001
Klisyri
A tirbanibulin product containing tirbanibulinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tirbanibulin is registered in 12 of 19 countries.
Countries holding a registration under ATC D06BX03 (tirbanibulin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Tirbanibulin · ATC D06BX03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- tirbanibulinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- D06BX03
- ATC class
- Tirbanibulin
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680683220013Btl 5 StkCHF 67.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tirbanibulin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomKlisyri 10mg/g ointment 250mg sachetsAlmirall Ltd
- United StatesKlisyriAlmirall, LLC
- SpainKLISYRI 10 MG/G POMADAAlmirall S.A.
- FinlandKlisyriAlmirall S.A.
- IrelandKlisyri 10 mg/g ointmentAlmirall, S.A.
- BelgiumKlisyri 10 mg/gAlmirall
- ItalyKLISYRI*unguento cutaneo 5 buste 250 g 10 mg/gALMIRALL S.A.
- NetherlandsKlisyri 10 mg/g, zalfGrupo Farmacéutico Almirall S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Klisyri
- Liechtenstein · Klisyri
- Norway · Klisyri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce2d1c46-88f9-45a0-859a-ba40257c9f20 GET /v1/drugs/ce2d1c46-88f9-45a0-859a-ba40257c9f20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tirbanibulinum 10 mg",
"valid_from": "2025-06-01",
"limitations": "[{\"description\":\"KLISYRI wird vergütet für die topische Feldtherapie nicht hyperkeratotischer, nicht hypertropher aktinischer Keratosen im Gesicht oder auf der Kopfhaut bei Erwachsenen.</b>\\nBei Auftreten von Rezidiven oder neuen aktinischen Keratosen im behandelten Bereich nach 8 Wochen ist eine alternative Behandlung in Betracht zu ziehen.</b>\\n</b> \\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-06-01\",\"validTo\":\"2028-05-31\"}]",
"galenic_form": "Salbe 2.5 mg/250 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-06-01",
"self_retention_pct": 10
}See everything about tirbanibulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.